Work

AKT inhibition: a bad AKT inhibitor in liver injury and tumor development?

Year: 2016

Type: article

Abstract: Cells respond to growth signals by activating internal programs that coordinate growth, division and death. One of these, the PI3K/AKT pathway, is frequently activated in human cancer (1). The serine/threonine kinase AKT is a key actor that regulates development, metabolism and the immune response (2,3).

Source: Translational Cancer Research

DOI: 10.21037/tcr.2016.11.44

Authors: Anna Joy, Burt Gary Feuerstein

Institutions: University of Arizona, University of Arizona College of Medicine- Phoenix

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W2560384270

FWCI: 0.173

Cites:

Cited by: 1

Related to: 10